Palliative care in poor-performance status small cell lung cancer patients: Is there a mandatory role for chemotherapy?

Supportive Care in Cancer

Volumn 20, Issue 11, 2012, Pages 2721-2727

  Baldotto, Clarissa Seródio ^a   Cronemberger, Eduardo Henrique ^b   De Biasi, Paulo ^a   Zamboni, Mauro ^a   Sousa, Aureliano ^a   Zukin, Mauro ^a   Small, Isabelle A ^a   Ferreira, Carlos Gil ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Centro Regional Integrado de Oncologia (CRIO)   (Brazil)

Author keywords

ECOG PS; Small cell lung cancer; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; LACTATE DEHYDROGENASE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; BRAZIL; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; LIFE EXPECTANCY; LUNG SMALL CELL CANCER; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SUPERIOR CAVA VEIN SYNDROME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAZIL; CARCINOMA, SMALL CELL; FEMALE; HOSPITALIZATION; HUMANS; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84868446446     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1392-0     Document Type: Article

References (33)

1. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841
2. Chua YJ, Steer C, Yip D (2004) Recents advances in management of small-cell lung cancer. Cancer Treat Rev 30:521-543
3. Ihde DC (1992) Chemotherapy of lung cancer. N Engl J Med 327:1434-1441
4. Lassen UN, Østerlind K, Hirsch FR, Bergman B, Dombernowsky P, Hansen HH (1999) Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression. Br J Cancer 79:515-519
5. Quoix E, Hedelin G, Popin E, Charloux A, Dietemann A, Seibert R et al (1993) Can we predict very short long term survival in small cell lung cancer? Lung Cancer 10:229-238
6. Bremnes RM, Sundstrom S, AasebØ U, Kaasa S, Hatlevoll R, Aamdal S et al (2003) The value of prognostic factors in small cell lung cancer: results from a randomized multicenter study with minimum 5-year follow-up. Lung Cancer 39:303-313
7. Yip D, Harper P (2000) Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer 28:173-185
8. Paesmans M, Sculier JP, Lecomte J, Thiriaux J, Libert P, Sergysels R et al (2000) Prognostic factors for patients with small cell lung cancer carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 89:523-533
9. Hauser CA, Stockler MR, Tattersall MHN (2006) Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Support Care Cancer 14:999-1011
10. Karnofsky DA, Abelmann WH, Craver LF et al (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma Cancer 1:634-656
11. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655
12. Taylor AE, Olver IN, Sivanthan T et al (1999) Observer error in grading performance status in cancer patients. Support Care Cancer 7:332-335
13. Albain KS, Crowley JJ, LeBlanc M et al (1990) Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group database. J Clin Oncol 8:1563-1574
14. Buccheri G, Ferrigno D (1994) Prognostic factors in lung cancer: tables and comments. Eur Respir J 7:1350-1364
15. Paesmans M, Sculier JP, Lecomte J et al (2000) Prognostic factors for patients with small cell lung carcinoma. Cancer 89:523-533
16. van Meerbeeck JP, Fennell DA, De Ruysscher DKM (2011) Smallcell lung cancer. The Lancet DOI:. doi:10.1016/S0140-6736(11) 60165-7
17. Sakuragi T, Oshita F, Nagashima S, Kasai T, Kurata T, Fukuda M et al (1996) Retrospective analysis of the treatment of patients with small cell lung cancer showing poor performance status. Jpn J Clin Oncol 26:128-133
18. Kenmotsu H, Goto K, Kubota K, Ohmatsu H, Niho S Yoh K, et al. (2008) Clinical significance of chemotherapy for small cell lung cancer (SCLC) with ECOG performance status (PS) 3-4. J Clin Oncol 26 s: abstr 19123.
19. Barbera L, Paszat L, Qiu F (2008) End-of-life in lung cancer patients in Ontario: aggressiveness of care in the population and a description of hospital admissions. J Pain Symptom Manag 35:267-274
20. Alvarez MP, Rubio OG, Cosp XB, Varela YA (2009) Chemotherapy versus best supportive care for extensive small cell lung cancer. Cochrane Database Syst Rev (4):CD001990.
21. Lassen UN, Østerlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH (1995) Long-term survival in small-cell lung cancer: post treatment characteristics in patients surviving 5 to 18+ years - an analysis of 1,714 consecutive patients. J Clin Oncol 13 (5):1215-1220
22. Rawson NSB, Peto J (1990) An overview of prognostic factors in small cell lung cancer: a report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer 61:597-604
23. Maestu I, Pastor M, Gomez-Codina J, Aparicio J, Oltra A, Herranz C et al (1997) Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic índex and validation of three known prognostic indices on 341 patients. Ann Oncol 8:547-553
24. Okamoto H, Watanabe K, Kunikane H, Yokoyama A, Kudoh S, Asakawa T et al (2007) Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer 97:162-169
25. Lilenbaun RC, Huber RM, Treat J, Masters G, Kaubitzsch S, Lane S et al (2006) Topotecan therapy in patients with relapsed smallcell lung cancer and poor performance status. Clin Lung Cancer 8:130-134
26. Mackay HJ, O'Brien M, Hill S, Lees SM, Thatcher N, Smith IE et al (2003) A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer. Clin Oncol 15:181-185
27. Garassino MC, Torri V, Michetti G et al (2010) Outcomes of smallcell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis. Lung Cancer. doi:10.1016/j.lungcan.2010.09.009
28. Morris J, Woolnough K, Sheldon J, Nanda U, Beckett P (2009) An audit of SCLC patients not receiving chemotherapy. Lung Cancer 63:S10
29. Koedoot CG, De Haes JC, Heisterkamp SH et al (2002) Palliative chemotherapy or watchful waiting? A vignettes study among oncologists. J Clin Oncol 20:3658-3664
30. Winter MC, Potter VA, Woll PJ (2008) Raised serum urea predicts for early death in small cell lung cancer. Clin Oncol 20:745-750
31. Østerlind K, Andersen PK (1986) Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 46:4189-4194
32. Radford JA, Ryder WDJ, Dodwell D (1993) Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis. Eur J Cancer 29A:81-86
33. McNiff KK, Neuss MN, Jacobson JO et al (2008) Measuring supportive care in medical oncology practice: Lessons learned from the quality oncology practice initiative. J Clin Oncol 26:3832-3837